Benzinga - Gainers
- BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital Market.
- Greenbrook TMS Inc. (NASDAQ: GBNH) shares gained 21.2% to $0.40 in pre-market trading. Greenbrook TMS recently entered into equity purchase agreement with Alumni Capital LP.
- Digital World Acquisition Corp. (NASDAQ: DWAC) gained 21% to $16.17 in pre-market trading. Digital World reached settlement with the SEC, paving way for Form S-4 registration statement review.
- Emergent BioSolutions Inc. (NYSE: EBS) shares gained 16.2% to $8.20 in pre-market trading after the FDA approved the company's two-dose anthrax vaccine for adults.
- T2 Biosystems, Inc. (NASDAQ: TTOO) shares rose 15.8% to $0.1159 in pre-market trading. The FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test.
- Phunware, Inc. (NASDAQ: PHUN) rose 11.5% to $0.4321 in pre-market trading. Phunware recently announced strategic cost saving measures to accelerate path to profitability.
- POSCO Holdings Inc. (NYSE: PKX) shares rose 11.5% to $108.02 in pre-market trading.
- LiveWire Group, Inc. (NYSE: LVWR) rose 10.6% to $11.39 in pre-market trading. LiveWire Group is expected to release its second quarter financial results on July 27, 2023.
- TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares climbed 10.2% to $0.32 in pre-market trading. TRACON Pharmaceuticals recently released the results of a six-month independent data monitoring committee (IDMC) review for the ongoing ENVASARC Phase 2 trial.
- Guardforce AI Co., Limited (NASDAQ: GFAI) gained 9.2% to $7.03 in pre-market trading. Guardforce AI shares jumped 57% on Thursday after the company announced it partnered with Concorde Security to launch a new robotic security solution in Singapore.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Sigma Additive Solutions, Inc. (NASDAQ: SASI) fell 39.2% to $0.2369 in pre-market trading.
- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) fell 15.4% to $0.5320 in pre-market trading. Pharmaceuticals received deficiency letter from NASDAQ. The compliance period for the company will expire on Jan. 15, 2024 - 8K.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) fell 10.8% to $0.49 in pre-market trading after gaining 15% on Thursday. Lytus Technologies recently shared updates on progress on its IPTV and Broadband Services.
- Sirius XM Holdings Inc. (NASDAQ: SIRI) shares fell 9.8% to $7.05 in pre-market trading after gaining 42% on Thursday. Pivotal Research downgraded Sirius XM from Hold to Sell, while Evercore ISI Group analyst Vijay Jayant downgraded the stock from In-Line to Underperform.
- Eliem Therapeutics, Inc. (NASDAQ: ELYM) shares fell 8.7% to $2.72 in pre-market trading. Eliem Therapeutics shares gained over 6% on Thursday after the company decided to explore strategic alternatives.
- Hillstream BioPharma, Inc. (NASDAQ: HILS) fell 8% to $0.3855 in pre-market trading after gaining 10% on Thursday. Hillstream Biopharma recently expanded its collaboration with Minotaur Therapeutics and its license agreement with OmniAb to advance next-generation targeted knob biologics (picobodies) against HER3 and a new undisclosed oncology target.
- DSS, Inc. (NYSE: DSS) fell 7.2% to $0.2562 in pre-market trading. DSS recently appointed Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
- BioSig Technologies, Inc. (NASDAQ: BSGM) fell 7.2% to $1.29 in pre-market trading. BioSig shares gained 7% on Thursday after the company's subsidiary was selected to join NVIDIA Inception program to support R&D collaboration on AI medical device platform for hospitals..
- Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares fell 6.1% to $3.91 in pre-market trading after gaining over 22% on Thursday.
- Intuitive Surgical, Inc. (NASDAQ: ISRG) fell 4.8% to $331.00 in pre-market. Intuitive Surgical reported better-than-expected earnings for its second quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: American Express, SLB And 3 Stocks To Watch Heading Into Friday
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.